New Zealand markets open in 9 hours 38 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
107.50-0.71 (-0.65%)
At close: 04:00PM EDT
106.20 -1.30 (-1.21%)
Pre-market: 08:16AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close108.21
Bid106.70 x 1100
Ask107.01 x 1000
Day's range105.78 - 107.81
52-week range91.51 - 122.16
Avg. volume1,475,403
Market cap247.72B
Beta (5Y monthly)0.26
PE ratio (TTM)35.13
EPS (TTM)3.06
Earnings dateN/A
Forward dividend & yield1.57 (1.46%)
Ex-dividend date25 Mar 2022
1y target est129.88
  • GlobeNewswire

    Novo Nordisk A/S: Share repurchase programme

    Bagsværd, Denmark, 15 August 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme in

  • Motley Fool

    3 Stocks to Buy and Hold Forever

    Three Motley Fool contributors have identified stocks to buy and hold forever. Here's why they chose Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Eli Lilly): If you're planning to hold a stock forever, then you need to be comfortable with its growth potential.

  • Zacks

    Prothena (PRTA) Q2 Earnings Miss, Pipeline Progress in Focus

    Prothena (PRTA) incurs a loss in the second quarter while revenues miss estimates.